Media
Press Releases
November 14, 2025
Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
November 13, 2025
Lupin Establishes a New Global Standard in Sustainable Pharma with an S&P Global ESG Score of 91
November 12, 2025
Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility
November 8, 2025
Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After Successful Inspection and Assessment
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comElise Titan
Director, U.S. Communications
elisetitan@lupin.comSmart Guide
Close
CloseSearch Product